Target intelligence / Profile preview

Rhophilin Rho GTPase binding protein 2 pseudogene 1 (RHPN2P1)

Target
RHPN2P1
Molecular classification
Other (Pseudogene)
01

Overview

Rhophilin Rho GTPase binding protein 2 pseudogene 1 (RHPN2P1) is classified as a pseudogene in humans and is not known to produce a functional protein product[3][6]. It is predicted to be involved in the negative regulation of stress fiber assembly but lacks demonstrated biological activity or clear disease associations[3]. As a pseudogene, RHPN2P1 is not considered a therapeutic target, and there are currently no drugs or biomarkers associated with it. Its role, if any, is likely limited to genomic or transcriptional regulation rather than direct protein function. Key points: - RHPN2P1 is a pseudogene, not a canonical gene coding for a functional protein[3][6]. - There is no evidence that it encodes a druggable target or participates in disease mechanisms as a direct effector. - Pseudogenes often have no biological function, but some may have regulatory impacts at the transcript level; this has not been demonstrated for RHPN2P1[3]. - Most databases (GeneCards, NCBI) clarify its pseudogene status and lack of association with established pathways, functions, disease roles, or pharmacology[3][6].

Other names
Putative rhophilin-2-like protein RHPN2P1Rhophilin-2 pseudogene 1

Beyond the preview

Go deeper on Rhophilin Rho GTPase binding protein 2 pseudogene 1 (RHPN2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rhophilin Rho GTPase binding protein 2 pseudogene 1 (RHPN2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call